Over 67% of the world suffers from herpes (cold sores), yet a breakthrough treatment, Pritelivir, remains out of reach.
Pritelivir is safer and way more effective than the 30+ year-old drugs Acyclovir and Valacyclovir. It significantly stops herpes outbreaks, reduces transmission, and doesn’t carry the risk of kidney damage like current treatments.
The FDA delayed its progress for years, citing animal studies, but the hold was lifted in 2017 after all concerns were addressed. So why isn’t it available yet?
This isn’t just about convenience—it’s about health, dignity, and hope for millions. We need MAHA to take action now to push for Pritelivir’s release and end the era of cold sores for good.
Speak up, share, and demand change—let’s make this happen. Let’s end herpes, it’s as simple as pushing the release and global availability of Pritelivir!